# A Clinical Double Blind, Randomized Study of the Efficacy of Hyperuricemia Treatment With Anserine Product.

> **NCT00208000** · PHASE2 · UNKNOWN · sponsor: **China Medical University Hospital**

## Conditions studied

- "Hyperuricemia,Anserine"

## Interventions

- **DRUG:** Marine active

## Key facts

- **NCT ID:** NCT00208000
- **Lead sponsor:** China Medical University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2004-07
- **Primary completion:** —
- **Final completion:** 2006-04
- **Target enrollment:** — (—)
- **Last updated:** 2010-11-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00208000

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00208000, "A Clinical Double Blind, Randomized Study of the Efficacy of Hyperuricemia Treatment With Anserine Product.". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00208000. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*